Zeo ScientifiX, Inc. 8-K

What Happened Zeo ScientifiX, Inc. (ZEOX) filed an 8-K (Item 5.02) reporting that on June 10, 2026 the company awarded multiple option grants under its 2021 Incentive Stock Plan. The company granted (a) 625,000 fully vested options to each of Greyt Ventures LLC (a principal stockholder/consultant), Ian Bothwell (CEO, CFO and director) and George Shapiro (CMO and director), exercisable cashless for 10 years at an exercise price of $1.67 per share; (b) an additional 625,000 “Incentive Options” to each of those three, which vest upon achievement of performance milestones, are cashless-exercisable when vested through ten years from the award date, and are described as antidilutive for any future transaction issuing 10% or more of the company’s fully diluted common stock; and (c) 80,000 fully vested options to non-executive director Chuck Bretz, exercisable for five years at $1.67 per share. The 8-K was filed June 12, 2026.

Key Details

• Award date: June 10, 2026; 8-K filed June 12, 2026 (Item 5.02).
• Grants: three recipients (Greyt Ventures LLC, Ian Bothwell, George Shapiro) each received 625,000 immediately vested options + 625,000 performance-based Incentive Options; Chuck Bretz received 80,000 fully vested options.
• Exercise price/terms: $1.67 per share; fully vested grants exercisable cashless for 10 years (5 years for Bretz’s grant); Incentive Options exercisable cashless upon vesting through 10 years from award.
• Antidilution clause: Incentive Options are described as antidilutive for any future transaction that issues 10% or more of the company’s fully diluted common stock.

Why It Matters These awards represent immediate and potential equity compensation to the CEO, CMO, a principal stockholder/consultant and a director. For investors, the key implications are potential dilution if options are exercised and management/insider alignment via equity-based awards. The Incentive Options include an unusual antidilution provision for large future stock issuances, which may affect how those options interact with any substantial financing or transaction; investors should review the company’s outstanding share count and recent filings to assess potential dilution and monitor any company disclosures about milestone achievement or option exercises.